HFEA Patient Feedback

Infertility Support

Supporting Assisted Conception, Parenting, Adoption, Surrogacy and Living Child Free. FertilityFriends.co.uk Limited is a Non-Profit UK Registered Company dedicated to providing free support services.

Adoption

Adoption isn't one of the easiest things to navigate. Come and speak with others who have or are going through the same difficult but rewarding process.

Parenting after infertility

We have many members who are lucky enough to become  parents. Through our parenting section we help our parents connect to each other and provide peer support.
Home
Not the time to change policy on donor anonymity
Friday, 14 December 2007

It is slightly more than two and a half years since UK law regarding donor anonymity was changed, and which now allows individuals aged 18 or over who were conceived following donor conception undertaken since April 2005 to learn the identity of their donor.

This change in legislation was not universally endorsed; it was opposed by associations with strong medical orientations, the British Fertility Society, the British Medical Association and the Royal College of Obstetricians and Gynaecologists. The position of the BMA was especially interesting since the recommendation of its Ethics Committee, supporting the removal of anonymity, was rejected by the Association’s membership (British Medical Association, 2004).

Concerns about the removal of donor anonymity centre on two major areas:

   1.      the potential impact on donor supply;
   2.      the willingness of parents to inform their donor-conceived children about their conception.

The government made clear that, since parliament had quite recently debated and voted on donor anonymity, it did not propose that the Human Fertilisation and Embryology Bill, currently before the House of Lords, should be used as an opportunity to re-examine the issue. Indeed, the Bill proposes to extend the rights of donor–conceived people to learn the identity of “donor half siblings” (where necessary consent is provided). When the Human Tissue and Embryos (Draft) Bill (Department of Health, 2007), precursor to the Human Fertilisation and Embryology Bill (2007), was reviewed by a joint committee of the House of Lords and House of Commons earlier this year, the committee proposed an even more radical measure (not included in the present Bill) that the birth certificates of donor-conceived people should be annotated in a way that would indicate the nature of their conception (House of Lords and House of Commons, 2007).

It seems, however, that the BMA, at least, wishes parliament to debate the issue of donor anonymity once more, in the hope that legislators will reverse their previous decision. In a briefing on the Bill, the Association states:

"Anonymity of donors
The BMA opposed the removal of donor anonymity which Parliament approved in the 2004 Human Fertilisation and Embryology Authority (Disclosure of Donor Information) Regulations. Since April 2005, anyone registering to be a donor has done so knowing that any child born as a result of the donation can seek identifying information about them once the child reaches the age of 18. The BMA is disappointed that the Government has not taken the opportunity of this bill to review the policy.

The BMA believes that the removal of donor anonymity has had a detrimental impact upon the availability of treatment with donor gametes. Despite reports from the HFEA that the number of men registering as sperm donors has increased, the number of women registering as egg donors continues to fall. The number of people registering as donors may not give an accurate picture of the number of donor conception treatments taking place and the length of time that prospective patients have to wait for treatment.

The BMA would like to see increased openness between parents and their donor-conceived children. We are concerned that the removal of donor anonymity may have made such openness less likely. Parents who are unwilling for their child to make contact with the donor when they reach 18 may be less likely to tell their child they were donor conceived” (British Medical Association, 2007).

While it is reassuring that the BMA has not subscribed to the “donor crisis” moral panic, it should be noted that a shortage of donors is reported in many countries, including those that protect donor anonymity. The only exceptions appear to be in countries where donors are paid and where, unlike the UK, commodification of women’s reproductive capacity is considered acceptable. In any event, the argument concerning donor recruitment begs completely the question as to whether the ethical issues (as identified originally by the BMA Ethics Committee) should so easily be trumped by utilitarian considerations.

The most surprising (and disappointing) element of the BMA position given that it represents a profession strongly committed to evidence-based practice, is the claim that the removal of donor anonymity might make it less likely that parents would tell their donor-conceived children about their conception. There is absolutely no evidence to support this position.

It has to be said that, in a context historically lacking in transparency - the result of accepted medical practice that considered it best for all concerned for donor conception to be undertaken “discretely” (a practice itself totally devoid of an evidence base) - evidence is in chronic short supply. However, what evidence that does exist runs counter to the BMA position.

In 1984 Sweden became the first country in the world to remove donor anonymity. Prior to the change in Swedish legislation, in a study reported by Milsom and Bergman (1982) only 1 of 92 couples interviewed intended to tell their child that they had been conceived using donor conception.

In 2000, Gottlieb et al. reported that 11% of parents of donor-conceived children studied had told their children about the nature of their conception (6% of parents of children born between 1983 and 1986 [i.e. before the change in legislation] and 18% of parents of children born after 1987). A further 40% of parents interviewed stated their intention to tell their child “later”. This same group of parents was interviewed again some years later (Lalos et al., 2007). By the second interview, 61% had already told their child about his or her conception, and a further 22%, who had not yet told their child(ren), were still intending to do so.


Indirect support for the Swedish findings is available in a forthcoming study drawing on the experiences of counsellors in UK licensed clinics (Crawshaw, in press). Half of the counsellors who were in post both before and after the removal of anonymity indicated that there had been an increase in the numbers of prospective parents stating their intention to tell their children about their origins. Taken together with those counsellors who said that, prior to the change in legislation, most prospective parents had stated their intention to tell their child, around 70% of parents indicated to counsellors their support for openness.

I make no claim that these studies prove that the change in legislation to remove donor anonymity has brought about changes in parental disclosure practice. However, they clearly do not support the claim that its removal will increase the likelihood that parents will not disclose, and are the only published evidence available that establishes any correlation between the legislative removal of donor anonymity and parental disclosure practices.

Already there are four distinct groups of donor-conceived people in the UK, distinguished by different opportunities to access information about their genetic history:

   1.  those who were conceived as a result of a procedure undertaken prior to August 1991, for the majority whom no records exist at all, but who may be able to ascertain information about/existence of genetic relatives via the voluntary contact register maintained by UKDonorLink;

   2.  those who were conceived as a result of a procedure undertaken between August 1991 and June 2004, who will have access to generally limited non-identifying donor information held by the Human Fertilisation and Embryology Authority;

   3.  those who were conceived as a result of a procedure undertaken between July 2004 and March 2005, who will have access to an increased range of non-identifying donor information held by the HFEA;


   4. those who were conceived as a result of a procedure undertaken after April 2005, who will have access to both non-identifying and identifying donor information.


It would be folly to change again the UK’s approach to donor anonymity. Not only would such a decision undermine the human rights of donor-conceived people, it would create considerable confusion among service providers and service users and further inequity between donor-conceived people.


References

British Medical Association (2004) Memorandum from the British Medical Association, Appendix 12. Ev 228. In House of Commons Science and Technology Committee (2005) ‘Human Reproductive Technologies and the Law’ Fifth Report of Session 2004-05. Vol II: Oral and Written Evidence http://www.publications.parliament.uk/pa/cm200405/cmselect/cmsctech/7/7ii.pdf

British Medical Association (2007) Human Fertilisation and Embryology Bill

House of Lords, November 2007 http://www.bma.org.uk/ap.nsf/Content/HFEBill?OpenDocument&Highlight=2,Human,Fertilisation,Embryology,Bill

Crawshaw, M. (in press) Prospective parents’ intentions regarding disclosure following the removal of donor anonymity. Human Fertility

Department of Health (2007) Human Tissue and Embryos (Draft) Bill. Cm 7087. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsLegislation/DH_074718

Gottlieb, C., Lalos, O. and Lindblad, F. (2000) Disclosure of donor insemination to the child: the impact of Swedish legislation on couples’ attitudes. Human Reproduction. 15: 2052-2056.

House of Lords and House of Commons (2007) Joint Committee on the Human Tissue and Embryos (Draft) Bill. Volume I: Report http://www.publications.parliament.uk/pa/jt200607/jtselect/jtembryos/169/169.pdf

Human and Fertilisation and Embryology Bill [HL] (2007) http://www.publications.parliament.uk/pa/ld200708/ldbills/006/2008006.pdf

Lalos, A., Gottlieb, C. and Lalos, O. (2007) Legislated right for donor-insemination children to know their genetic origin: a study of parental thinking. Human Reproduction 22(6): 1759–1768.

Milsom, I. and Bergman, P. (1982) A study of parental attitudes after donor insemination. Acta Obstetrica et Gynecologica Scandinavia. 61:125–128.


Eric Blyth CQSW BA MA PhD
Professor of Social Work
University of Huddersfield
Queensgate
Huddersfield HD1 3DH
England
Tel: +44 (0) 1484 472457
Fax: +44 (0) 1484 472794
http://www.hud.ac.uk/hhs/research/acs/staff/eb.htm

For more discussion on this article please [click here]  

 

 




Share or Bookmark the above article!
Reddit!Del.icio.us!Google!Live!Facebook!StumbleUpon!Newsvine!Fark!Blogmarks!Yahoo!Ma.gnolia!Squidoo!FeedMeLinks!BlinkBits!Tailrank!linkaGoGo!
 
HFEA calls for national strategy to reduce the biggest risk of fertility treatment - Multiple births
Tuesday, 04 December 2007

Image
HFEA Logo
The HFEA have today called for a professionally-led, coordinated national strategy to reduce the number of multiple births that occur following fertility treatment which contribute to significant numbers of premature and low birth weight babies.

An increased rate of twin births represents IVF's biggest risk for mothers and babies because they significantly raise the chances of mortality, prematurity, low birth weight and cerebral palsy for babies. It can also cause life-long term problems for children and risks to mothers, including preeclampsia, diabetes and heart disease.

Following the HFEA's public consultation on the best outcome for IVF babies, the Authority have concluded that they expect to see the multiple birth rate to fall to 10% following a 3 year national strategy.

The Authority have now called on the relevant professional bodies to lead on developing guidance on the best way to achieve this change across all types of fertility treatment, including those which fall outside the HFEA's regulatory system.

A recent study has shown that the rate of multiple births and the risks they bring to women and babies is disproportionate for all types of fertility treatment, but especially IVF. Although IVF treatment accounts for only 1.2% of all UK births, it accounts for nearly 1 in 5 of the multiple births in the UK.

Other fertility treatments have also been shown to contribute to a higher incidence of multiple births, including IUI, GIFT and drugs for ovarian stimulation. As some of these treatments fall outside the HFEA's remit, the Authority are calling for a national strategy, co-ordinated by the professional bodies to set out guidance on best clinical practice during treatments which cause a higher rate of multiple births.

Work on this strategy is due to begin in mid December, to begin the challenge of finding the best long term strategy for clinics to bring down their multiple birth rates. The progress of this work will be discussed at the Authority's open meeting in February 2008.


Walter Merricks, Interim Chair of the HFEA said:

"This issue about improving baby health and safety. Maximum safety means the way the body was designed, one baby at a time. As many as 126 IVF babies die each year as a result of being born as part of a multiple birth and many more can face serious health problems which can last a lifetime.

"We are not in the business of intervening in the decisions made between a patient and their doctor or sacrificing women's chances of conception by asking clinicians to force women to have treatments that offer low chances of success. But this is a real problem that has to be addressed.

 "The HFEA's latest clinic data has shown a slight increase in 2005 in the proportion resulting in both twin and triplet births following IVF, compared to 2004. It is clear that the increasing success of IVF is driving the number of multiple births up instead of down

"But the issue of multiple births and the problems that they can provide is bigger than just IVF and, therefore, bigger than just the area which the HFEA can influence. IUI, GIFT and drugs for ovarian stimulation also contribute to a higher incidence of multiple births. This is why we are calling for a co-ordinated, long term, national strategy to tackle this issue over time.

"The principles of good medical practice in this country are that it is evidence-based and professionally led. This issue is no exception - the profession needs to lead the way and the HFEA will do everything it can to support that.

"This approach means that the experts in this sector who treat patients every day will be able to decide on the detail of how this risk is reduced in a way that is workable for clinics and patients. This will take time, but we applaud the commitment shown already by the professional bodies and look forward to working closely with them to improve baby safety following IVF."

 

  • To read Walter Merricks (Interim Chair of the HFEA) speech on “Improving baby safety by reducing multiple births” please go to http://www.hfea.gov.uk/docs/mulitple-births-speech.pdf

  • To read the British Fertility Society’s press release welcoming the announcement made today by the HFEA please see below.

 




Share or Bookmark the above article!
Reddit!Del.icio.us!Google!Live!Facebook!StumbleUpon!Newsvine!Fark!Blogmarks!Yahoo!Ma.gnolia!Squidoo!FeedMeLinks!BlinkBits!Tailrank!linkaGoGo!
 
British Fertility Society response to the HFEA calls for national strategy to reduce multiple births
Tuesday, 04 December 2007


Dr Mark Hamilton, Chair of the British Fertility Society said:

“The BFS welcomes the announcement of the HFEA today which recognises that multiple birth rates after assisted reproduction treatment are high. The BFS responded to the HFEA consultation on multiple births earlier this year and the concluding remarks within the Society’s response were as follows:

The evidence base linking the practice of multiple embryo transfer and the consequent achievement of pregnancies at significantly greater risk of serious neonatal and maternal complications is well known.  All the major risks of morbidity and mortality are significantly increased for twins compared with singletons.  The BFS strongly believes that the health benefits to children, the reduction in distress for families and the enormous cost savings for society, through reduction in the need for immediate and long-term health care for affected children, make an overwhelming case for change in this area of clinical practice.  This view was shared in a recently published Consensus Statement (Human Fertility, 10:71-74 (2007)).  Modification of embryo transfer policy through careful patient and embryo selection can significantly reduce the risk of twins after IVF.  A balanced approach will allow clinicians to take into account the individual circumstances of any given patient without compromising the chances of conception.

There is broad support within BFS membership for initiatives which can remedy the current high numbers of multiple pregnancies after IVF. As providers of treatment we need to be seen to support the principle of offering the best for patients taking into account their individual circumstances as they progress through treatment.

The BFS believes that an approach where the regulator provides clinics with targets for multiple rates, expressed as a percentage of all pregnancies created, is sensible, allowing clinics themselves to determine how best to reform practice to achieve this end. It is reasonable for the Authority to provide guidance in this regard. The BFS would not favour an approach at this stage which was absolutely prescriptive as this would not prove popular with patients or clinics.

There is an urgent need for an adequately resourced public/professional education initiative to promote effective and safe embryo transfer policies. Over the next year the goal must be to change the national mindset around appropriate embryo transfer numbers. Furthermore the regulator absolutely must adopt an active role in promoting sound commissioning practice including adequate adoption by PCT’s of the NICE Guidelines relevant to IVF cycle definitions and numbers.

It is only through a dual approach whereby we encourage good practice and empower patients and professionals in decision making with reliable, understandable information that we can expect progress to be made.

The BFS looks forward to working with the regulator in advancing the safe delivery of care to the maximum number of people seeking fertility treatment in the United Kingdom.”



Share or Bookmark the above article!
Reddit!Del.icio.us!Google!Live!Facebook!StumbleUpon!Newsvine!Fark!Blogmarks!Yahoo!Ma.gnolia!Squidoo!FeedMeLinks!BlinkBits!Tailrank!linkaGoGo!
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Results 25 - 27 of 112

One at a time